Improvement in aspects of sleep with etanercept and optional adjunctive topical therapy in patients with moderate‐to‐severe psoriasis: results from the PRISTINE trial

Abstract

This study confirms that most patients with moderate-to-severe psoriasis have impaired sleep which is associated with impaired QoL. Treatment with etanercept significantly improved sleep, with most improvement occurring before a broad range of topicals were allowed. Sleep improvement was associated with improved QoL.